Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue that binds ghrelin receptors (GHS-R1a). Unlike less selective GHRPs, Ipamorelin produces GH release with minimal stimulation of cortisol, prolactin, or ACTH in research models — making it one of the cleanest GH secretagogue tools for research requiring isolated GH effects without confounding hormonal responses.
Research Applications
Selective GH secretagogue research
Ghrelin receptor biology studies
Hypothalamic-pituitary axis investigations
GHRH + GHRP synergy combination protocols
Body composition and metabolic GH research
Quality Specifications
Purity: ≥98% (HPLC verified)
Compound: Ipamorelin
Molecular Weight: 711.86 Da
Form: Lyophilized powder
Storage: -20°C, protect from light
COA: Batch-specific, ISO-accredited laboratory
Frequently Asked Questions
Q: What makes Ipamorelin selective? A: It binds the ghrelin receptor with minimal off-target stimulation of ACTH, cortisol, or prolactin — a cleaner research profile for isolated GH axis studies than GHRP-6 or GHRP-2.
Q: Why combine with CJC-1295? A: Ipamorelin acts on ghrelin receptors; CJC-1295 acts on GHRH receptors. Two independent pathways produce synergistic GH output in research models.
Q: What does GH secretagogue research study? A: GH pulse patterns, downstream IGF-1 production, body composition effects, metabolic rate, and tissue repair signaling cascades.
